Cardiac Risks With Newer Psoriasis Meds Match TNF Inhibitors ...Middle East

Medscape - News
Cardiac Risks With Newer Psoriasis Meds Match TNF Inhibitors
A study of biologic-naive patients with psoriasis or PsA found that IL-17, IL-12/23, and IL-23 inhibitors have comparable cardiovascular and thrombotic risk profiles as TNF inhibitors. Medscape Medical News

Hence then, the article about cardiac risks with newer psoriasis meds match tnf inhibitors was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Cardiac Risks With Newer Psoriasis Meds Match TNF Inhibitors )

Apple Storegoogle play

Last updated :

Also on site :